Valuation: Boston Scientific Corporation

Market Cap 71.03B 60.87B 56.94B 52.06B 98.24B 6,801B 99.29B 674B 262B 3,415B 267B 261B 11,299B P/E 2026 *
18.3x
P/E 2027 * 19.3x
Enterprise Value 79.74B 68.34B 63.93B 58.45B 110B 7,636B 111B 757B 294B 3,834B 299B 293B 12,686B EV / Sales 2026 *
3.73x
EV / Sales 2027 * 3.42x
Free-Float
82.47%
Yield 2026 *
-
Yield 2027 * -
1 day-2.70%
1 week-4.71%
Current month+4.88%
1 month+10.76%
3 months-15.18%
6 months-34.78%
Current year-48.60%
1 week 48.77
Extreme 48.77
52.56
1 month 42.55
Extreme 42.55
52.99
Current year 42.2
Extreme 42.2
100.9
1 year 42.2
Extreme 42.2
109.5
3 years 42.2
Extreme 42.2
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Date Insider Type Main position Quantity % Market Cap.
11/08/26 Other

Controller/Auditor

2,930 0.0002%
10/08/26 Other

Chief Financial Officer

9,908 0.0007%
05/08/26 Buy

Director

2,100 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-2.70%-4.71%-53.84%-2.82% 71.03B
-0.08%+7.38%+25.75%+16.86% 232B
-1.71%+6.16%+1.56%-15.16% 151B
-1.38%-4.29%-21.55%+30.78% 132B
+0.47%+3.56%-15.82%-11.66% 52.46B
+0.79%-0.34%+10.60%+20.65% 52.16B
-3.50%+3.35%+26.14%+28.40% 43.33B
+0.01%+0.74%+35.92%+51.47% 40.36B
-0.84%+2.51%-1.37%+8.42% 33.51B
+0.40%+5.48%-20.86%+45.52% 33.53B
Average -0.70%+1.96%-1.35%+17.25% 84.2B
Weighted average by Cap. -0.62%+2.80%+1.32%+13.15%

Financials

2026 *2027 *
Net sales 21.37B 18.31B 17.13B 15.66B 29.55B 2,046B 29.87B 203B 78.82B 1,027B 80.22B 78.48B 3,399B 22.33B 19.14B 17.9B 16.37B 30.89B 2,138B 31.21B 212B 82.37B 1,074B 83.84B 82.03B 3,552B
Net income 3.84B 3.29B 3.08B 2.81B 5.31B 368B 5.37B 36.42B 14.16B 185B 14.41B 14.1B 611B 3.69B 3.16B 2.96B 2.7B 5.1B 353B 5.15B 34.97B 13.6B 177B 13.84B 13.54B 586B
Net Debt 8.72B 7.47B 6.99B 6.39B 12.06B 835B 12.19B 82.7B 32.16B 419B 32.73B 32.02B 1,387B 5.45B 4.67B 4.37B 4B 7.54B 522B 7.62B 51.72B 20.11B 262B 20.47B 20.03B 867B
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
24/08/26 $49.01 -2.70% 22,027,880
21/08/26 $50.37 +2.03% 35,992,162
20/08/26 $49.37 -5.08% 20,390,548
19/08/26 $52.01 +3.05% 16,834,155
18/08/26 $50.47 -1.87% 11,724,272
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
49.01USD
Average target price
62.69USD
Spread / Average Target
+27.91%

Quarterly revenue - Rate of surprise